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I. EFFECTS OF GLASGOW OUTCOME SCALE MISCLASSIFICATION 
ON TRAUMATIC BRAIN INJURY CLINICAL TRIALS 
 
 The Glasgow Outcome Scale (GOS) is the primary endpoint for efficacy analysis of 
clinical trials in traumatic brain injury (TBI). Accurate and consistent assessment of 
outcome after TBI is essential to the evaluation of treatment results, particularly in the 
context of multicenter studies and trials. The inconsistent measurement or interobserver 
variation on GOS outcome, or for that matter, on any outcome scales, may adversely 
affect the sensitivity to detect treatment effects in clinical trial. The objective of this study 
is to examine effects of nondifferential misclassification of the widely used five-category 
GOS outcome scale and in particular to assess the impact of this misclassification on 
detecting a treatment effect and statistical power. We followed two approaches. First, 
outcome differences were analyzed before and after correction for misclassification using 
a dataset of 860 patients with severe brain injury randomly sampled from two TBI trials 
with known differences in outcome. Second, the effects of misclassification on outcome 
distribution and statistical power were analyzed in simulation studies on a hypothetical 
800-patient dataset. Three potential patterns of nondifferential misclassification (random, 
upward and downward) on the dichotomous GOS outcome were analyzed, and the power 
of finding treatments differences was investigated in detail. All three patterns of 
misclassification reduce the power of detecting the true treatment effect and therefore 
lead to a reduced estimation of the true efficacy. The magnitude of such influence not 
only depends on the size of the misclassification, but also on the magnitude of the 
treatment effect. In conclusion, nondifferential misclassification directly reduces the 
power of finding the true treatment effect. An awareness of this procedural error and 
methods to reduce misclassification should be incorporated in TBI clinical trials. 
 
II. IMPACT OF MISCLASSIFICATION ON THE ORDINAL GLASGOW 
OUTCOME SCALE IN TRAUMATIC BRIAN INJURY CLINICAL 
TRIALS 
 
The methods of ordinal GOS analysis are recommended to increase efficiency and 
optimize future TBI trials. To further explore the utility of the ordinal GOS in TBI trials, 
this study extends our previous investigation regarding the effect of misclassification on 
the dichotomous GOS to examine the impact of misclassification on the 5-point ordinal 
scales. The impact of nondifferential misclassification on the ordinal GOS was explored 
via probabilistic sensitivity analyses using TBI patient datasets contained in the IMPACT 
database (N=9,205). Three patterns of misclassification including random, upward and 
downward patterns were extrapolated, with the pre-specified outcome classification error 
distributions. The conventional 95% confidence intervals and the simulation intervals, 
which account for the misclassification only and the misclassification and random errors 
together, were reported. Our simulation results showed that given a specification of a 
minimum of 80%, modes of 85% and 95% and a maximum of 100% for both sensitivity 
and specificity (random pattern), or given the same trapezoidal distributed sensitivity but 
a perfect specificity (upward pattern), the misclassification would have caused an 
underestimated ordinal GOS  in the observed data. In another scenario, given the same 
trapezoidal distributed specificity but a perfect sensitivity (downward pattern), the 
misclassification would have resulted in an inflated GOS estimation. Thus, the 
probabilistic sensitivity analysis suggests that the effect of nondifferential 
misclassification on the ordinal GOS is likely to be small, compared with the impact on 
the binary GOS situation. The results indicate that the ordinal GOS analysis may not only 
gain the efficiency from the nature of the ordinal outcome, but also from the relative 
smaller impact of the potential misclassification, compared with the conventional binary 
GOS analysis. Nevertheless, the outcome assessment following TBI is a complex 
problem. The assessment quality could be influenced by many factors. All possible 
aspects must be considered to ensure the consistency and reliability of the assessment and 
optimize the success of the trial. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
III. A METHOD FOR REDUCING MISCLASSIFICATION IN THE 
EXTENDED GLASGOW OUTCOME SCORE 
 
The eight-point extended Glasgow Outcome Scale (GOSE) is commonly used as the 
primary outcome measure in traumatic brain injury (TBI) clinical trials. The outcome is 
conventionally collected through a structured interview with the patient alone or together 
with a caretaker. Despite the fact that using the structured interview questionnaires helps 
reach agreement in GOSE assessment between raters, significant variation remains 
among different raters. We introduce an alternate GOSE rating system as an aid in 
determining GOSE scores, with the objective of reducing inter-rater variation in the 
primary outcome assessment in TBI trials. Forty-five trauma centers were randomly 
assigned to three groups to assess GOSE scores on sample cases, using the alternative 
GOSE rating system coupled with central quality control (Group 1), the alternative 
system alone (Group 2), or conventional structured interviews (Group 3). The inter-rater 
variation between an expert and untrained raters was assessed for each group and 
reported through raw agreement and with weighted kappa (k) statistics. Groups 2 and 3 
without central review yielded inter-rater agreements of 83% (weighted k¼0.81; 95% CI 
0.69, 0.92) and 83% (weighted k¼0.76, 95% CI 0.63, 0.89), respectively, in GOS scores. 
In GOSE, the groups had an agreement of 76% (weighted k¼0.79; 95% CI 0.69, 0.89), 
and 63% (weighted k¼0.70; 95% CI 0.60, 0.81), respectively. The group using the 
alternative rating system coupled with central monitoring yielded the highest inter-rater 
agreement among the three groups in rating GOS (97%; weighted k¼0.95; 95% CI 0.89, 
1.00), and GOSE (97%; weighted k¼0.97; 95% CI 0.91, 1.00). The alternate system is an 
improved GOSE rating method that reduces inter-rater variations and provides for the 
first time, source documentation and structured narratives that allow a thorough central 
review of information. The data suggest that a collective effort can be made to minimize 
inter-rater variation. 
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EFFECTS OF GLASGOW OUTCOME SCALE MISCLASSIFICATION ON TRAUMATIC 
BRAIN INJURY CLINICAL TRIALS 
 
Introduction 
Accurate and consistent assessment of outcome after TBI is essential to the evaluation of 
treatment results, particularly in the context of multicenter studies and trials. Various studies have 
investigated inter-observer agreement and misclassification of TBI outcome measures commonly 
used in TBI studies, and in general found that interobserver variation or misclassification on GOS 
outcome does exist (Anderson et al., 1993; Brooks et al., 1986; Choi et al., 2002; Maas et al., 1983; 
Marmarou, 2001; Pettigrew et al., 2003; Scheibel et al., 1998; Teasdale et al., 1998; Wilson et al., 
1998; Wilson et al., 2002; Wilson et al., 2007), ranging from 17% (Marmarou, 2001) to 40% 
(Wilson et al., 2007) in practices. Previous work has shown that this could attenuate the true 
treatment effect and reduces the power of detecting the efficacy of treatment (Choi et al., 2002). 
However, little is known on how different misclassification directions or patterns might affect 
analysis of treatment effects in double-blinded TBI trials. It would seem reasonable to suspect that 
misclassification in a clinical trial would possibly effect both the treatment and control groups 
equally. However, even in this case, there is a profound effect on the analysis of the treatment 
effects (Choi et al., 2002). In clinical practice, nondifferential misclassification may affect the GOS 
outcome through three potential patterns: The random pattern refers to the misclassification 
between the adjacent categories that have an equal rate or chance of being classified for both 
treatment groups.  The upward pattern means more true outcome categories are classified into better 
outcome categories for both groups; the downward pattern means more true outcome categories are 
classified into less optimistic outcome categories for both groups. The objective of this study is to 
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investigate whether these three potential patterns of measurement error may have differential effects 
on the power of finding treatment differences in double blinded TBI trials. 
 
Materials and Methods 
Misclassification  
Misclassification in this paper is defined as an incorrect classification of the GOS outcome 
in TBI trials. Furthermore, for the purpose of discussing the outcome analysis of a double-blinded 
TBI trial, we assume in this study that the rates of misclassification are the same for both treatment 
and control groups. Thus, the outcome misclassification discussed in this study is nondifferential or 
random, and as defined above includes three potential patterns: (1) random, (2) upward and (3) 
downward for both treated and control groups. Realizing that misclassification may be a 
combination of upward and downward grading in either the placebo or treatment group, we selected 
patterns, which combined both directions of misclassifications. More specifically, we defined the 
“upward” pattern as 20 % of patients in both control and treated groups misclassified to a higher 
outcome category and 10 % of patients   misclassified in a lower outcome category. The downward 
pattern was defined as 20 % of patients misclassified in a lower outcome category while 10 % of 
patients were misclassified to a higher category. These hypothetical percentages of misclassification 
are in the range of GOS misclassification found in other studies (Anderson et al., 1993; Maas et al., 
1983; Marmarou, 2001; Wilson et al., 1998). Our focus in this report is to study misclassification 
applied equally to placebo and treated groups. However, an imbalance or non-random 
misclassification among treated and control groups is not considered in this report.  Among all five 
categories of GOS outcome [Death (D), Vegetative (V), Severe Disability (SD), Moderate 
Disability (MD) and Good Recovery (GR)], only the category of death can be excluded from 
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misclassification, whereas the other four categories are all subject to misclassification, albeit to a 
different degree.  To study the effect of misclassification, it is assumed that a certain rate of 
misclassification exists in a patient’s outcome in two adjacent categories.   
Patient Data  
For analysis of the effect of misclassification on analysis of outcome differences, we used a 
dataset of 860 patients with severe brain injury randomly sampled from 2 TBI trials with known 
differences in outcome (Hukkelhoven et al., 2002).  
For a more detailed analysis of the effect of misclassification on outcome distribution and 
statistical power we used a hypothetical 800 patients dataset (400 patients in each arm). In this 
dataset a 55% favorable outcome and a 20% mortality outcome distribution was considered as 
baseline. For both approaches the GOS was dichotomized into favorable (GR/MD) versus 
unfavorable (SD/V/D).  
Statistical Method 
Three patterns of misclassification on dichotomized GOS were studied:  1) random pattern: 
20% GOS outcomes being equally misclassified between favorable and unfavorable outcome 
categories for both study groups, 2) upward pattern: 20% unfavorable outcomes being misclassified 
into favorable, and 10% favorable into unfavorable for both study groups, and 3) downward pattern: 
20% favorable outcomes being misclassified into unfavorable, and 10% unfavorable into favorable 
for both study groups.  For a dichotomous GOS outcome (GR/MD vs. SD/V/D), the simulated 
misclassification rates were only applied among survivors (i.e., between GR/MD and SD/V), 
however, all outcomes, including death, were assessed in the final outcome distribution 
measurement [i.e., (number of favorable outcomes/treatment total) - (number of favorable outcomes 
/control total).  
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Power Calculation 
In this study, the power was defined as the probability of finding the difference between the 
treatment and control groups with a 95% two-sided significance. The calculation was based on a 
range of hypothetical two-proportion comparisons. No covariates were considered to simplify the 
problem. The powers, under a hypothetical condition with no misclassification and three simulated 
cases with misclassification, were compared.  
The treatment effect in the hypothetical dataset was created following a conventional 
method (Bolland et al., 1998). For example, 10% treatment effect on a dichotomous GOS outcome 
[favorable (GR/MD) vs. unfavorable (SD/V/D)] was defined as an overall 10% outcome shift from 
the unfavorable to the favorable outcome in the treatment group, i.e. the favorable outcome in the 
treatment group increased by 10% and the unfavorable outcome decreased by 10% from the 
baseline.  
Further, recognizing no misclassification on the outcome of death within the unfavorable 
outcome category, we applied the hypothetical treatment effect into the outcome of death, and the 
remaining unfavorable outcomes (i.e. a combined SD and V) individually. For the outcome of 
death, 10% treatment effect was defined as a 10% absolute reduction of the baseline numbers, and it 
was assumed that 10% of patients’ outcomes were improved from death to better outcome 
categories including V and SD. Finally, the remaining numbers of unfavorable outcomes (SD/V) 
equaled the total treatment group minus 10% of the increased baseline favorable outcome numbers 
and minus 10% deducted baseline death numbers. The two-sided Chi-Square test was used for the 
dichotomous outcome comparisons.  
 
Results 
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Effect of Misclassification 
The effects of misclassification on the dichotomous outcome estimation were demonstrated 
by an actual phase III TBI trial patient dataset displayed in table 1.  It was assumed that there were 
certain rates of outcome categories being misclassified. Thus, reversing the hypothetical 
misclassified outcome numbers to the observed outcome data would be helpful in gauging the effect 
of misclassification on the outcome analysis and the three possible misclassification models were 
applied.  
 
Random Pattern 
In the random pattern, the adjacent outcome categories have an equal rate of being 
misclassified for both treatment and control groups. For example, in Table 1, it was assumed that 
equal rates (20%) of patients had been misclassified as favorable or unfavorable outcome for both 
groups. If these misclassified outcome numbers were corrected based on our assumptions, the true 
underlying number of patients with the favorable outcomes would be 308 for the treatment group, 
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264 for the control, and the percentage difference in favorable outcomes between the two groups 
would be (308 –264) / 430 or 10.2 % (p-value=0.002). The method for calculation is shown in the 
Table 1 legend.  Before the 20% misclassification correction, the observed difference is 7.9 and p-
value is 0.02. Thus, misclassification introduces an error of 2.3 % (10.2-7.9). 
Upward Pattern  
 The upward model resulted in an upward trend of misclassification for both treatment and 
control groups, where the rate of patients being misclassified was higher (20 %) from the 
unfavorable outcomes to the favorable outcomes than the rate exchange from the other direction 
(10%). If the misclassified outcome numbers were corrected, the number of patients with the 
favorable outcomes would be 264 for the treatment group, and 226 for the control. The actual  
percentage difference in favorable outcomes between the two groups would be 8.8 (p-value=0.009) 
instead of the observed difference of 7.9 (p-value=0.02). In this case, misclassification introduces an 
error of 0.9 % (8.8 – 7.9).  
Downward Pattern 
In the downward model, the rate of being misclassified was lower (10%) from the 
unfavorable outcomes to the favorable outcomes than the rate exchange from the other direction 
(20%) for both treatment and control groups. After the misclassified outcome numbers were 
corrected, the numbers of patients with the favorable outcome would be 312 for the treatment 
group, and 269 for the control. The percentage difference in favorable outcomes between the two 
groups would be 10.0 (p-value=0.002) resulting in misclassification error of 2.1 % (10.0 – 7.9).  
Thus, corrections for all three patterns of misclassification demonstrated a potential for 
greater outcome differences and smaller p-values than the observed dataset if the study assumption 
was true and the misclassification existed in the observed outcome measurement.  
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Misclassification and Outcome Distribution 
Table 2 illustrates the relationship between misclassification and the dichotomous outcome 
distribution under three misclassification models. A hypothetical 800-patient dataset (400 patients 
each group) with a 55% favorable outcome rate and 20% mortality rate was used for this 
illustration. 
 
In general, without an outcome difference (i.e., 0% treatment effect), the misclassified 
outcome numbers were the same for both treatment and control groups and the misclassification 
only resulted in outcome distribution shifts, but not in outcome differences for all three models. 
However, with an outcome difference (i.e., 5%, 10%, 15% treatment effect), the outcome 
distributions for the treatment group were different from the distributions for the control group.  As 
a result, the misclassified outcome numbers for the treatment and control groups were also different. 
For example, a 20% outcome number exchange between the favorable and unfavorable outcome 
categories in the random misclassification case caused the 5%, 10% and 15% outcome differences 
to decrease to 3.2%, 6.4% and 9.6%.  The reduction is 1.8%, 3.6% and 5.4% respectively from the 
previous outcome differences.  
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Similarly, in the upward (20% up and 10% down) and downward (20% down and 10% up) 
misclassification examples, after applying the rate exchange between the dichotomous outcome 
categories, the outcome differences (i.e., 5%, 10%, 15%) decreased to 3.7%, 7.4% and 11.1% 
(Upward), as well as 3.6%, 7.2% and 10.8% (Downward), which were 1.3%, 2.6% and 3.9% 
(Upward), as well as 1.4%, 2.8%, and 4.2% (Downward) reductions from the original outcome 
differences respectively.   
Thus, it is conceivable that the impact from a misclassification on a dichotomous outcome 
measurement is not only related to the misclassification but also depends on the outcome 
distributions of the two study groups. Regardless of the random, upward and downward patterns of 
misclassifications, for a fixed rate of misclassification, the dichotomous outcome difference 
depends on the size of treatment effect or the difference in outcome distribution between the 
treatment and control groups. This is illustrated in Table 2, where all three misclassification 
examples have revealed that the more the treatment group differs from the control, the greater the 
impact of misclassification. 
Misclassification and Power  
The powers of detecting the expected treatment effect and the misclassified treatment effect 
were compared and are illustrated in Figure 1a to 1c using the same hypothetical 800 patient 
dataset.  
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Figure 1a shows the effect of random misclassification pattern on the power. The solid line presents 
the correlation between the power and the expected treatment effect and dashed lines present the 
correlation between the random misclassified treatment effect and power according to the symbol 
key. For example, for the case of a 10 % treatment effect, a 20 % up and down random 
misclassification would result in a reduction of power from 82 % (point a) to 49 % (point b) thereby 
rendering the trial non-significant.  
 
 
Figure 1b shows the effect of upward misclassification pattern on the power. The solid line 
represents the correlation between the power and the expected treatment effect and dashed lines 
represent the correlation between the upward misclassified treatment effect and power according to 
the symbol key. For example, for the case of a 10 % treatment effect, a 20 % up and 10 % down 
(lowest dashed line) misclassification results in a reduction of power from 82 % (point a) to 60 % 
(point b). 
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Figure 1c shows the effect of downward misclassification pattern on the power. The solid line 
represents the correlation between the power and the expected treatment effect and dashed lines 
represent the correlation between the downward misclassified treatment effect and power according 
to the symbol key. For example, for the case of a 10 % treatment effect, a 10 % up and 20 % down 
(lowest dashed line) misclassification results in a reduction of power from 82 % (point a) to 55 % 
(point b). 
 
  An example of the effect of random pattern on the power is shown in Fig 1a.  Under a 
given treatment effect (i.e., the improved proportion of the favorable outcome in the treatment 
group), the power was inversely associated with the rate of the misclassification. For example, the 
power of detecting a 10% true treatment effect with a two-sided 95 percent significance is 82% 
(solid line), however, after the 5%, 10% and 20% misclassifications were applied to the expected 
treatment effect, the power of detecting the same 10% treatment difference decreased to 75%, 67% 
and 49% respectively.  Clearly, this was due to the altered outcome difference by the 
misclassification. The higher the misclassification rate, the smaller the treatment effect and the 
lower the power.  
Figure 1b and 1c demonstrate the effect of the upward and downward misclassification 
patterns on the power.  Similar results on reducing the power were observed, albeit in different 
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degrees. If using a power to detect a 10% treatment effect with a two-sided 95% significance as an 
example, the upward pattern with a combination of 5% up and 2.5% down, 10% up and 5% down 
and 20% up and 10% down were considered to be the rate exchange between the dichotomous 
outcome categories, then the desired 82% power would be decreased to 78%, 72% and 60% 
accordingly.  On the other hand, if the situation was reversed, namely downward pattern with 2.5% 
up and 5% down, 5% up and 10% down and 10% up and 20% down were used as the rate 
exchanges between the outcome categories, then the expected 82% power would be reduced to 
76%, 70% and 55%, respectively. 
 
Discussion 
Outcome measurements and outcome misclassification in trials of head injury 
The GOS is widely used for TBI outcome measurement (Jennett and Bond, 1975), and 
recommended as primary endpoint for assessing efficacy of novel therapeutic approaches in clinical 
trials. For purposes of analysis in clinical trials, the GOS is commonly dichotomized into favorable 
versus unfavorable outcome, collapsing the 5-point categorical outcome scale into a binary outcome 
measure (Bullock et al., 2002; Choi et al., 1998; Maas et al., 1997; Narayan et al., 2002; Teasdale et 
al., 1998; Wilson et al., 2002). Despite the acceptance of the GOS as a global functional outcome 
measure, it has been criticized as being insensitive, especially in the more favorable end of outcome 
(Bullock et al., 2002; Levin et al., 2001; Teasdale et al., 1998). The 8-point extended GOS (GOSE) 
has been introduced to increase sensitivity of outcome assessment, and the use of a structured 
interview is advocated to obtain more consistency in outcome assignment (Fayol et al., 2004; 
Wilson et al., 1998). Although the GOSE offers increased sensitivity, this benefit may be offset by a 
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higher rate of misclassification. Recent evidence indicates an agreement rate as low as 60% in 
GOSE by untrained investigators (Wilson et al., 2007). 
  Misclassification, especially the nondifferential misclassification, is a relevant issue in 
clinical trial design. Previous work indicated that random misclassification could mask the true 
efficacy and reduce the power of finding a treatment effect (Choi et al., 2002). By understanding the 
consequence of outcome misclassification, efforts could be made to improve the accuracy and 
consistency of outcome measurements.  
 The present study has confirmed the substantial effects of nondifferential misclassification 
on outcome analysis and statistical power under various scenarios. One may question whether the 
effects of misclassification are substantial enough to be important. Clearly, from our analysis, we 
have found that a treatment effect may be reduced from 10% to 6.8% by a 20% random 
misclassification (i.e. 20% up and 20% down), which is more than sufficient to render a trial 
ineffective.  The effect of misclassification on treatment effect is summarized in Table 3.  
 
 Moreover, the scenarios and the rates of misclassification investigated are not unrealistic 
to clinical practice. Marmarou (Marmarou, 2001) conducted a study within the American Brain 
Injury Consortium to ascertain the reliability of the GOS rating and found an upward shift of 17.4 
percent of severe patients to the moderate disability category. An upward shift of outcome 
assignment had been previously reported (Anderson et al., 1993) and is a likely result of the 
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optimism of a patient’s primary care providers who compare the improved outcome to the serious 
condition immediately after injury, rather than to the healthy pre-injury status. Conversely, a rigid 
application of the criteria from the structured interview or questionnaires by research workers tends 
to allocate patients to lower outcome categories (Teasdale et al., 1998; Wilson et al., 2007). 
Therefore, nondifferential misclassification may be found in either the upward or downward 
direction, based on different clinical scenarios.  It is for this reason, that three patterns were studied 
in this report.  
An Assessment of three possible misclassification patterns 
To demonstrate the effect of nondifferential misclassification on the outcome, we applied 
three possible patterns of misclassification on a real Phase III head injury trial data using 5-category 
GOS outcome distribution in Table 1. According to the results from previous studies, we assume 
that there were certain rates of nondifferential misclassification embedded in the observed dataset, 
we corrected the hypothetical misclassified outcome numbers to the observed data using three 
models. After the numbers were corrected, a larger outcome difference and a smaller p-value were 
revealed in all three misclassification patterns.  
Therefore, if the misclassification indeed existed in the past trial dataset as described in this 
study and as suggested by other studies, the true outcome difference would have been larger.  More 
importantly, our study indicated that regardless of which direction dichotomous outcome was 
misclassified (i.e., random, upward and downward), the effect of nondifferential misclassification 
always tends to reduce the true dichotomous outcome difference.  
It should be noted that the random and the downward patterns in our examples seemed to 
have a larger effect on reducing the outcome difference than the upward pattern. This is likely due 
to the outcome distribution being misclassified and the rates of misclassification being applied.  For 
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example, more outcome numbers were exchanged from the category of MD/GR (i.e., 20% MD/GR 
= (0.2)*(252) = 50) with the numbers of V/SD in the random or downward cases, as compared with 
the numbers that were exchanged (10% MD/GR = (0.1)*(252) = 25) in the upward case.  Thus, it is 
reasonable to understand why the random and the downward patterns had a larger impact on the 
outcome difference in our example.   
In summary, the true outcome difference is always affected more by a higher 
misclassification rate and a larger difference in outcome distributions between the treatment and 
control groups. Therefore, any procedures that minimize the misclassification, such as proper 
outcome measurement techniques and the methods for improving the inter-observer agreement, 
should be indicated according to this study. Experience in the recent Phase III clinical trial on 
Dexanabinol showed that training of outcome assessors can be highly effective (Wilson et al., 
2007). 
Differential effects of Misclassification in Treatment and Control Groups 
Although it is generally assumed that the rate of the misclassification under a blinded 
clinical trial condition is the same for both control and treatment groups (i.e., nondifferential or 
random misclassification), the effect of the misclassification on these two are unlikely to be the 
same in the presence of a treatment effect. This is a consequence of the different outcome 
distribution between treatment groups, as illustrated in Table 2. 
For example, in the random misclassification (20% up/down) case, with no treatment effect, 
the misclassified outcome numbers are the same for both treatment and control groups; the 
misclassification only resulted in an outcome distribution shift but not in an outcome difference. 
However, with a treatment effect (i.e., 5%, 10%, 15%), the misclassified outcome numbers for the 
treatment and control groups are no longer the same, i.e., more patients’ outcome in the treatment 
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group are affected by the misclassification due to a larger outcome difference. Thus, instead of 
having an 5%, 10%, 15% in treatment effect, only a 3.4%, 6.8%, 10.2% outcome difference results, 
which represents a 1.6%, 3.2% and 4.8% reduction of the previous outcome difference respectively.  
The other two patterns followed a similar trend as well. Figure 2 shows the example of 
correlation between upward misclassifications and reduction of treatment effect using same 
hypothetical 800 patient data as in Table 2. 
 
Figure 2 illustrates the reduction of treatment effect by upward outcome misclassification. The solid 
line represents the expected treatment effect and dashed lines represent the reduction of treatment 
effect by the upward misclassifications according to the symbol key. For example, for the case of a 
10 % treatment effect, a 30 % up (lowest dashed line) misclassification results in a reduction of 
treatment effect to 7.6%, which is 2.4% reduction from the expected 10% treatment effect. 
 
For a fixed rate of misclassification, the outcome difference depends on the size of treatment 
effect or the difference in outcome distribution between the treatment and control groups. For 
example, after a 20% upward misclassification, the expected 5%, 10%, 15% and 20% outcome 
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differences were reduced to 4.2%, 8.4%, 12.2% and 16.6% respectively. On the other hand, for a 
fixed treatment effect, the effect of misclassification on outcome difference depends on the rate of 
misclassification.  For example, after 5%, 10%, 20% and 30% biased upward misclassification, an 
expected 10% treatment effect was reduced to 9.4%, 9.2%, 8.4%, and 7.6% respectively.  
The implication here is that if a study drug does have an effect on improving the patients’ 
outcome, the treatment group is likely to be affected more by the misclassification than the control 
group. The more a treatment differs from the control, the greater the number of patients affected by 
the misclassification, leading to a greater reduction in the true outcome difference.    
It is important to note that the demonstration on the dichotomous outcome distribution can 
also be applied to more than two category distributions. For example, if there is a larger difference 
between MD and GR, the true difference between these two categories will be affected more by 
misclassification. Likewise, if a larger difference exists between SD and MD, the actual difference 
between these two will be decreased more as a result of the misclassification. This topic will be 
studied in greater detail in the future.   
Dealing with misclassification 
Since all GOS categories can be misclassified except death and as the affected outcome 
numbers are associated with the treatment effect and/or the outcome distribution, one might relate 
the issue to the choice of outcome measurements in head injury clinical trials. One study has 
suggested that an increase in outcome categories leads to an increase in misclassifications, and 
several other studies have proved that inter-observer disagreement is much higher in the 8-category 
GOS than that in the 5-category GOS (Choi et al., 2002; Maas et al., 1983). These observations 
underline the notion that the outcome measurement with fewer outcome categories might be less 
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affected by the misclassification. A careful balance will need to be sought between the desire for 
more sensitive expanded outcome measures and adverse effects of misclassification. 
We suggest that both outcome misclassification and the sensible outcome measurement are 
important issues in the TBI trial design, which, in turn, is directly associated with the success of a 
trial. However, both the strategy to minimize the outcome misclassification, and to select a sensible 
outcome measurement should be considered separately. Although outcome misclassification is 
unavoidable, it is possible that errors in classification may be reduced.  Accordingly, procedures 
such as structured interviews, proper outcome information resources, quality assurance of outcome 
evaluation and properly trained personnel have been previously shown to be successful approaches 
of minimizing the misclassification (Marmarou, 2001; Pettigrew et al., 2003; Wilson et al., 1998; 
Wilson et al., 2007).  These measures as well as developing new strategies are recommended in the 
clinical trial design.  
On the other hand, carefully examining the outcome distribution from Phase II trials and 
selecting a sensitive outcome measurement to match each individual outcome distribution should be 
considered.  For instance, if a treatment effect was mainly focused between the moderate and severe 
disability categories or other adjacent GOS categories, a dichotomous outcome would be a better 
choice over more GOS categories (Choi et al., 2002).  However, if more or all categories of the 
GOS are affected by the treatment, then the dichotomous GOS would be less powerful than using 
more GOS categories  
Effect of Misclassification on power and sample size 
Recognizing that outcome misclassification has a significant potential to reduce the true 
treatment effect, one would naturally relate this consequence to the power and sample size of a trial 
design. For a typical Phase III TBI trial, a sample size of 800 patients (i.e. 400 patients in treatment 
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group, 400 in placebo group) is required in order to detect an absolute treatment effect that increases 
the proportion of favorable outcomes from 50% to 60% with 80% power and 5% significance. We 
used a similar design to examine the effect of outcome misclassification on the desired power in the 
TBI trial. The correlation between the power and three potential patterns of misclassification was 
depicted in Figures 1a through 1c. 
 As one might expect, in parallel with the effect of reducing the true outcome difference, 
all three patterns of misclassification have an inverse effect on the power. For instance (Figure 1a), 
without misclassification, the expected power of detecting a 10% treatment effect (i.e., improving 
favorable outcome from 55% to 65% in the treatment group in our example) was 82%; with the 
same condition and a 10% random (i.e. 10% up and 10% down) misclassification for both study 
groups, the power of detecting such effect decreased to 67%; similarly, the powers under the 
upward (i.e.10% up and 5% down), and the downward (i.e. 10% down and 5% up) misclassification 
condition reduced the power from 82 % to 72% and 70% respectively.  Clearly, the examples 
shown in this study demonstrate that the desired power to detect the treatment effect could be 
compromised by misclassification of the dichotomous GOS outcome; the greater the number of 
outcomes misclassified, the greater the degree of power compromised. 
Compensation for Reduced Power due to Misclassification 
 As misclassification reduces power, it would seem reasonable to simply increase the 
sample size to compensate for the power reduction. This can be done.  However, increasing the 
sample size can only raise the power but cannot compensate for treatment effect due to 
misclassification.   Using our previous example in Table 3., a 10% random misclassification can 
reduce the original 10% treatment effect to 8.4%, and the power was subsequently reduced from 
80% to 66.5% for detecting 8.4% treatment effect. In this example, one can increase the sample size 
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from 800 to 1094 in order to raise the power from 66.5% to 80% for detecting 8.4% treatment 
effect, but still, the increased sample size cannot compensate the 1.6% (10%-8.4%) treatment 
reduction. This further emphasizes the importance of designing procedures to minimize the effect of 
misclassification.  In summary, the only way to blunt the reduction of treatment effect is to reduce 
misclassification.  
 
Conclusions 
All three patterns of nondifferential misclassification act to attenuate the treatment effect 
and reduce the power of detecting the true treatment effect. In the case of a positive drug effect, 
misclassification leads to a conservative estimation of the true efficacy. The magnitude of such 
influence not only depends on the size of the misclassification, but also on the magnitude of 
treatment effect. Nondifferential misclassification directly reduces the power of finding the true 
treatment effect. If the outcome of the treatment arm is worse, then misclassification acts to blunt 
the difference between placebo and treatment. Thus, an awareness of this procedural error and 
methods to reduce misclassification should be incorporated in TBI clinical trials. 
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IMPACT OF MISCLASSIFICATION ON THE ORDINAL GLASGOW OUTCOME SCALE 
IN TRAUMATIC BRIAN INJURY CLINICAL TRIALS 
 
Introduction 
Several recent studies (Bath et al., 2008; Optimizing Analysis of Stroke Trials (OAST) 
Collaboration 2007; McHugh et al., 2010) have explored the ordinal analysis of the 5-point ordinal 
Glasgow Outcome Scale (GOS) (Jennett and Bond, 1975) and other ordinal outcomes commonly 
used in Traumatic Brain Injury (TBI) and stroke clinical trials. Previously, studies have 
dichotomized GOS outcomes which split the GOS as an unfavorable (dead, vegetative status and 
severe disability) versus favorable (moderate disability and good recovery) outcome. Recent 
methodologic work indicates that analyzing ordinal outcomes as ordinal gives substantial gains over 
conventional dichotomized outcomes. Therefore, it is strongly recommended that both ongoing and 
future TBI and stroke trials using original ordinal outcomes and use methods of ordinal analyses.   
To further explore the utility of the ordinal GOS in TBI trials, this study extends our 
previous investigation (Lu et al., 2008) regarding the effect of misclassification on the dichotomous 
GOS, to examine the impact of misclassification on the 5-point ordinal scales. In the previous study, 
we used a simple sensitivity analysis to explore three patterns of nondifferential misclassification on 
the dichotomous GOS and its impact on the efficacy analysis and statistical power. The results 
suggested that all three patterns of misclassification act to attenuate the treatment effect and reduce 
the statistical power. In the case of a positive drug effect, misclassification leads to a conservative 
estimation of true efficacy. 
In this study, we explored the impact of nondifferential misclassification on the 5-point 
ordinal scales via a probabilistic sensitivity analyses (Fox et al., 2005; Lash and Fink, 2003). 
Probabilistic sensitivity analysis is an extension of simple sensitivity analysis in which the study 
assigns probability distributions to misclassification parameters, rather than a single value or a 
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series of discrete values within a range. By using a range of possible sensitivity and specificity 
parameters, the analysis calculates simulation intervals that portray the presumed uncertainty as 
more plausible misclassification. The final simulation intervals account for uncertainties from both 
outcome misclassification and random errors. The results will help investigators to better 
understand the impact of misclassification on the 5-point ordinal outcome in TBI trials in a 
quantitative manner.  
 
Materials and Methods 
Patient data 
We used patient data from the IMPACT Database (Marmarou et al., 2007) as examples of 
typical selected head injury populations.  The IMPACT project was an international collaboration 
linking researchers in Belgium, Netherlands, United Kingdom and United States of America, which 
was funded by National Institutes of Health (NIH) and aimed to develop methodologies to improve 
the design and analysis of clinical trials of head injury.  The IMPACT database contains clinical 
data on 9,205 individual patients with moderate or severe head injury, from eight randomized 
controlled trials (RCTs) (n = 6,535) and three observational epidemiologic studies (n = 2,670). The 
patient data from RCTs represent the head injury population with more restricted inclusion criteria, 
whereas the data from the observational studies represent the population with more generalized 
characteristics.  
For each individual study in the IMPACT Database, 400 subjects were randomly sampled 
with replacement, as the baseline samples or the placebo group. Another 400 subjects were 
randomly sampled from each placebo group with replacement, as the treatment group, respectively.  
Thus, each individual dataset was generated representing the general TBI population from RCTs 
and observational studies.  
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The treatment effect was simulated for the treatment group within each study based on the 
assumption that the effect of drug treatment followed a proportional odds model (McCullagh, 1980). 
The common odds ratio (COR) was calibrated so that there would be an overall 10% (COR=1.5) 
increase in the proportion of patients with a favorable outcome in the treatment group. 
Nondifferential ordinal GOS outcome misclassification  
The 5-point ordinal GOS includes categories of good (GR), moderate disability (MD), 
severe disability (SD), vegetative status (VS) and death (D). The categories of VS and D were 
combined and analyzed as one category in the study. In the context of double blind clinical trials, it 
was assumed that the misclassification on the outcome was non-differential, that is, the outcome 
misclassification was the same for both treated and control groups. Further, two assumptions were 
made to simulate the misclassification on the 5-point ordinal GOS outcome. First, the 
misclassification was made between two adjacent categories only, with a same set of biased 
parameters. For example, the misclassification was made between the categories of GR and MD and 
between MD and SD only, with a same sensitivity and specificity. Second, no misclassification was 
made for the category of VS, thus, for the combined category of VS and D.  
Probabilistic sensitivity analysis on the ordinal outcome misclassification 
In this study, we used the concept of the probabilistic sensitivity analysis introduced by Lash 
and Fink (2003) and Fox et al. (2005) and modified the SENSMAC (SAS Macros) by Fox and 
colleagues. The original SENSMAC was generated to provide probabilistic sensitivity analysis to 
quantify likely effects of misclassification of a dichotomous outcome, exposure or covariate. We 
modified the misclassification section of the SAS macros to explore the impact of ordinal GOS 
misclassification on TBI trials. The modification was mainly done for the category of MD where 
the misclassification could be made to both directions, that is, between MD and GR and between 
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MD and SD. Since the assumption was that the misclassification can only be made between two 
adjacent outcome categories, the reclassification for MD was performed through two independent 
binary situations as illustrated by the Figure 1. As a result, the terms of sensitivity and specificity 
were maintained for the two binary situations and the overall reclassified MD was recalculated 
accordingly.  
 
Figure 1 illustrates the reclassification process for the category of Moderate Disability (MD) for 
which the misclassification can be made to both directions. The study assumes the misclassification 
is between the two adjacent categories only, i.e., between the categories of Good Recovery (GR) 
and MD and of MD and Severe disability (SD). Thus, the reclassification for the category of MD is 
performed through two independent binary situations first, and then recalculated based on the 
observed MD, and the differences between the reclassified MD with GR and the observed MD and 
between the reclassified MD with SD and the observed MD. 
 
Three patterns of nondifferential misclassification 
Three potential patterns of nondifferential misclassification were simulated to examine the 
impact of misclassifications on the 5-point ordinal GOS in TBI trials, including the patterns of 
random, upward and downward (Figure 2). For the random pattern, we specified a trapezoidal 
distribution (minimum of 80%, modes of 85 and 95%, and a maximum of 100%) for both 
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sensitivity and specificity; for the upward pattern, we specified trapezoidal distribution (minimum 
of 80%, modes of 85 and 95%, and a maximum of 100%) for sensitivity and a perfect specificity; 
while for the downward pattern, we specified a trapezoidal distribution (minimum of 80%, modes 
of 85 and 95%, and a maximum of 100%) for specificity and a perfect sensitivity. 
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Figure 2 shows the output of sensitivity and specificity examples based on 5,000 iterations that are 
used to describe the patterns of nondifferential misclassification. For the random pattern, we 
specified a trapezoidal distribution (minimum of 80%, modes of 85 and 95%, and a maximum of 
100%) for both sensitivity and specificity; for the upward pattern, we specified trapezoidal 
distribution (minimum of 80%, modes of 85 and 95%, and a maximum of 100%) for sensitivity and 
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a perfect specificity; while for the downward pattern, we specified a trapezoidal distribution 
(minimum of 80%, modes of 85 and 95%, and a maximum of 100%) for specificity and a perfect 
sensitivity. 
 
Analysis and output 
To conduct the probabilistic sensitivity analysis, we first randomly sampled a probability 
from each defined bias parameter distribution, followed by using the selected probability to correct 
for the outcome misclassification. After reclassification of each subject who was simulated to have 
been misclassified, a summary measure was estimated and saved to a reconstructed dataset. This 
reconstructed dataset represents a possible point estimate that could have occurred after correcting 
for misclassification, based on the probability distributions specified for sensitivity and specificity. 
The estimation of ordinal GOS was assessed using a proportional odds model and reported via a 
common odds ratio for the treatment versus the placebo group. No covariate was involved in the 
analysis.  
For each study and each pattern of misclassification, the entire process described above was 
repeated 5,000 times to create a distribution of common odds ratios, which represented the 
corrected estimations (correcting for the misclassification only). The 95% simulation limits, which 
are the 2.5th and 97.5th percentiles of the corrected point estimates and the median estimate, were 
reported.   
The study also took account of random error by calculating a standard error estimate for the 
log common odds ratio from the observed dataset, randomly choosing a standard normal deviate, 
and subtracting the product of this deviate and the standard error of the conventional point estimate. 
This process was also repeated 5,000 times for each reconstructed dataset, yielding a frequency 
distribution of odds ratios corrected for both systematic and random errors. Thus, three intervals 
were reported: the conventional 95% confidence limits (accounting for random error only), the 
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simulation limits that account for the misclassification only, and for both misclassification and 
random errors.  
 
Results 
Distribution of the 5-point GOS at the six month post injury 
Table 1 shows the six month GOS outcome data that was used to explore the impact of 
ordinal outcome misclassification in TBI clinical trials. The outcome datasets were randomly 
sampled from eight RCTs and three observational studies contained in the IMPACT Database, 
representing the moderate to severe head injury population with either more restricted inclusion 
criteria (RCTs) or more generalized characteristics (observational studies). Each data set contains 
800 patients with 400 in each arm. A 10% treatment effect was simulated for the treatment group to 
symbolize a trial effect.  
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In general, most studies had a ‘U’ shaped outcome distribution at the six month post injury, 
that is, large proportions of patients had outcomes of either good recovery or combined mortality 
and vegetative status, and relatively lower percentages of patients had outcomes of moderate or 
severe disabilities. The proportions of GR and VS/D among RCTs ranged from 22.0% (SKB) to 
42.3% (TIUS) and from 25.5% (HITII) to 35.3% (SKB), respectively, while the proportions among 
the observational studies ranged from 18.8% (TCDB) to 30% (EBIC) and from 36.5% (EBIC) to 
46.3% (TCDB), respectively. The proportions of MD and SD among the RCTs ranged from 15.5% 
(TINT) to 28% (PEG) and from 10.8% (HITII) to 19.5% (HITI), respectively, whereas the 
proportion among the observational studies ranged from 17.3% (EBIC) to 18.9% (UK4) and from 
16.3% (EBIC) to 18.2% (UK4), accordingly. 
As expected, the baseline GOS at the six month among the RCTs were better than the 
outcomes from the observational studies. The proportions of favorable outcome (GR and MD) were 
higher among the RCTs, compared with the proportions among the observational studies; whereas 
the mortalities were lower among the RCTs, as compared with the mortalities among the 
observational studies.  
Probabilistic sensitivity analysis: correcting for nondifferential misclassification errors of ordinal 
GOS  
Table 2 shows the results of the ordinal GOS analyses by the conventional approach, as well 
as the probabilistic sensitivity analysis correcting for the nondifferential misclassification. The 
conventional analysis was performed on each observed dataset, from which a perfect outcome 
classification was assumed and 95% confidence intervals took account for random errors only. 
Among all studies, the common odds ratios of more favorable outcome, as compared between the 
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treatment and  placebo group, ranged from 1.35 (PEG) (95% C.I., 1.06 - 1.71) to 1.62 (TINT) (95% 
C.I. 1.25 - 2.09).  
 
Misclassification with random and upward patterns 
The probabilistic sensitivity analysis correcting for the misclassification with a random 
pattern was demonstrated by a trapezoidal distribution specified for sensitivity and specificity, with 
a minimum 80%, modes of 85% and 95%, and a maximum of 100% for each. The 95% simulation 
limits, which are the 2.5th and 97.5th percentiles of the back calculated point estimates, and the 
corresponding median estimates moved upward slightly as compared to the results of the 
conventional approach for all studies. The actual simulation intervals (accounting for 
misclassification only) ranged from 1.29 - 1.51 (PEG) to 1.56 - 1.80 (TINT) and the corresponding 
median estimate ranged from 1.39 to 1.67. The overall 95% simulation limits (accounting for both 
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misclassification and random errors) ranged from 1.06 - 1.82 (PEG) to 1.29 – 2.18 (TINT) 
accordingly.  
Given the specified sensitivity (minimum of 80%, modes of 85 and 95%, and a maximum of 
100%) and specificity (100%) parameters, the analysis results correcting for the misclassification 
with an upward pattern were similar to the results correcting for the misclassification with a random 
pattern. The 95% simulation limits ranged from 1.29 - 1.44 (PEG) to 1.57 - 1.77 (TINT) and the 
corresponding median estimate ranged from 1.36 to 1.66.  The overall 95% simulation limits ranged 
from 1.06 - 1.76 (PEG) to 1.28 – 2.17 (TINT) accordingly. If a random or upward pattern of 
nondifferential misclassification existed within the error ranges specified, the ordinal GOS from the 
observed datasets would have been underestimated by a small degree.  
Misclassification with a downward pattern 
In contrast, given the specification of the sensitivity (100%) and specificity (minimum of 
80%, modes of 85 and 95%, and a maximum of 100%) parameters, the analysis results correcting 
for the misclassification with a downward pattern were quite different from the results correcting 
for the random and upward misclassification. The 95% simulation limits and the corresponding 
median estimate moved substantially downward for all studies, so did the overall 95% simulation 
limits for all studies. For the downward pattern, the 95% simulation intervals ranged from 0.94 – 
1.07 (PEG) to 1.37 - 1.49 (TINT), and the corresponding median estimates ranged from 1.01 to 
1.43. The overall simulation limits ranged from 0.78 – 1.31 (PEG) to 1.11 – 1.84 (TINT) 
accordingly. If a downward pattern of nondifferential misclassification existed within the assumed 
error ranges, the ordinal outcome from the observed datasets would have been inflated. 
 
Discussion 
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We explored the impact of nondifferential misclassification on the 5-point ordinal scales 
among TBI studies using a probabilistic sensitivity analysis. The analysis involved reconstructing 
the data that would have been observed had the misclassified variable been correctly classified, 
given the sensitivity and specificity of classification. We have demonstrated that nondifferential 
misclassification could produce uncertainties for the 5-point ordinal GOS analysis in TBI trials. For 
instance, our simulation results showed that a) given a specification of a minimum of 80%, modes 
of 85% and 95% and a maximum of 100% (random pattern) for both sensitivity and specificity or b) 
given the same trapezoidal distributed sensitivity but a perfect specificity (upward pattern), the 
misclassification would have caused an ordinal GOS underestimated in the observed data drawn 
from the IMPACT database (Marmarou et al., 2007).  In another scenario, given the same 
trapezoidal distributed specificity but a perfect sensitivity (downward pattern), the misclassification 
would have resulted in an inflated GOS estimation. 
It is highly possible that the primary outcomes such as GOS and Extended GOS (GOSE) 
could have been misclassified to some extent in the TBI trials. Various studies have investigated 
misclassification and inter-observer variation of the TBI outcome measures and in general found 
that the variation does exist (Anderson et al., 1993; Brooks et al., 1986; Maas et al., 1983; 
Marmarou, 2001; Pettigrew et al., 1998; Scheibel et al., 1998; Teasdale et al., 1998; Wilson et al., 
1998; Wilson et al., 2002; Wilson et al., 2007) The reported overall disagreement in GOS 
assessments ranged from 8% (Wilson et al., 1998)  to 30% (Brooks et al., 1986); whereas the 
disagreement in GOSE ratings ranged from 22% (Wilson et al., 1998) to 41% (Wilson et al., 2007) 
in practices. When the overall disagreement in GOS assessment (collapsed from GOSE) from the 
study was broken down to individual categories (Wilson et al., 2007), the disagreement in rating the 
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categories of SD, MD and GR, between an expert and the untrained investigators, was 29.5%, 
53.3% and 35% accordingly.  
Three patterns of nondifferential misclassification  
Our current analyses suggest that the scenarios of misclassification investigated are not 
unrealistic to clinical practice. Marmarou (2001) conducted a study among 34 American Brain 
Injury Consortium members to ascertain the reliability of the GOS rating. The results showed that 
the rating for 20.6% of Moderate patients was shifted to the Good Recovery GOS category and 
32.3% of severe patients were rated as moderately disabled.  An upward shift of outcome 
assignment had been previously reported (Anderson et al., 1993) and is a likely result of the 
optimism of the patient’s primary care providers who compare the improved outcome to the serious 
condition immediately after injury, rather than to the healthy pre-injury status. Conversely, a rigid 
application of the criteria from the structured interview or questionnaires by research workers tends 
to allocate patients to lower outcome categories (Teasdale et al., 1998; Wilson et al., 1998). 
Therefore, nondifferential misclassification may be found in either the upward or downward 
direction, based on different clinical scenarios. 
Correlation between the nondifferential misclassification and the probabilities of GOS categories 
 In this study, it appears that the impact of nondifferential misclassification on the 5-point 
ordinal GOS is less significant, compared with the effect of misclassification on the previously 
reported binary GOS (Lu et al., 2008). This is likely due to the probabilities or the prevalence of 
GOS categories which were misclassified. The examples of the correlation between the 
nondifferential misclassification and GOS category probabilities are given in Table 3. We propose 
that three GOS category probability sets (i.e., equal probability, the “U” shaped distribution and 
single dominant category) reflect the true outcome distribution, whereas the GOS assessment is 
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done with errors. The classification errors were illustrated via a simple model, in which 20% of 
patients in category GR were classified as being in MD, 20% MD being  in GR, 20 % of patients in 
category MD  being in SD, and 20 % SD  being in MD for both placebo and treatment groups. As a 
result, the true category probabilities given at the beginning of each case are transformed by 
misclassification into the observed probabilities in the rows of ‘Random misclassification.’  
 
The results from our examples confirmed that the effect of misclassification on the cases of 
equal probability and “U” shaped distribution is relatively small. However, given the same error 
rates and treatment effect, the random misclassification caused the true outcome to be substantially 
underestimated  in a  single dominant GOS scenario, and the true outcome difference between 
placebo and treatment group reduced from 10% (OR=1.5) to 7.4% (OR=1.35). The scenario is 
similar with the effect of misclassification on binary GOS data. Thus, the impact of 
misclassification will likely be less sensible in the equal probability and the “U” shaped ordinal 
GOS distributions as observed in 11 TBI studies presented in Table 2.  
Advantages and limitations of the probabilistic sensitivity analysis 
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Taken together, the scenario and the simulation intervals extrapolated by this study are in 
accordance with the previous study results. We applied a trapezoidal distribution to describe the 
misclassification parameters and patterns. The distribution is specified by four points: the lower 
(80%) and upper bounds (100%) and the lower (85%) and upper (95%) modes, between which the 
probability density is flat and equal to these modes, representing the zone of indifference. Thus, 
unlike the simple sensitivity analyses, the results from this probabilistic sensitivity analysis provide 
a sense of central tendency of the corrected ordinal GOS estimate.  The results also provide a 
measure of uncertainty in the corrected estimate, as portrayed by the simulation limits.  The 
confidence limits provided also include both classification and random errors. More significantly, 
our simulation study was based on data from eight major Phase III trials in TBI and three 
observational TBI studies.  As such, we believe that our findings may be applicable to a wide range 
of trials in TBI.  
It should be pointed out that, similar to all simulation studies, the main limitation of this 
study was that the distribution of the assumed misclassification parameter may be arbitrary, which 
could lead to different distributions of the adjusted analysis. Furthermore, the informed sensitivity 
analysis may be limited by the absence of any sense of weight to yield various results, such as the 
rate of misclassification between GR and MD or between MD and SD. In practice, the rate of 
misclassification may well be different between GR (good recovery) and MD (moderate disability) 
versus between MD and SD (severe disability). 
 
Conclusions 
In conclusion, the probabilistic sensitivity analysis in this study suggests that given the 
classification error ranges, the effect of nondifferential misclassification on the 5-point ordinal GOS 
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is likely to be small, compared with the impact on the binary GOS situation. The findings were 
consistent across eight major Phase III IBT trials and three observational studies. The results 
support the notion that the ordinal GOS analysis may not only gain the efficiency from the nature of 
the ordinal outcome, but also from the relative smaller impact of the potential misclassification, as 
compared with the conventional binary GOS analysis. Nevertheless, the outcome assessment 
following TBI is a complex problem. The assessment quality could be influenced by many factors. 
All possible aspects must be considered to ensure the consistency and reliability of the assessment 
and optimize the success of the trial. 
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A METHOD FOR REDUCING MISCLASSIFICATION IN THE EXTENDED GLASGOW 
OUTCOME SCORE 
 
Introduction 
The eight-point extended Glasgow Outcome Scale (GOSE) was introduced (Jennett et al., 
1981) to increase sensitivity of the primary outcome assessment in traumatic brain injury (TBI) 
trials. However, its assessment appears to be more complex and susceptible to inter-rater variation, 
as has been suggested by several sets of authors (Brooks et al., 1986; Maas et al., 1983; Marmarou, 
2001), compared to the original version, the five-point Glasgow Outcome Scale (GOS; Jennett and 
Bond, 1975). 
Conventionally, eight-point GOSE outcome data are collected through a structured interview 
with the patient, alone or together with a caretaker (Wilson et al., 1998). The structured interview is 
designed to reduce inter-rater variation through standardizing the questions relative to assessment, 
and to assist raters in recording the explicit reasons for classification into each GOSE category. 
Despite the fact that using the structured interview questionnaires helps reach acceptable agreement 
in GOSE assessment between raters (Pettigrew et al., 1998; Teasdale et al., 1998; Wilson et al., 
1998), significant variation remains among different raters. A recent study using the structured 
interviews indicated an agreement rate as low as 59% (weighted kappa [κ]=0.72; 95% confidence 
interval [CI] 0.62, 0.75) for GOSE assessment by untrained investigators (Wilson et al., 2007). 
 Inter-rater variation in primary outcome rating is a serious concern that may have 
contributed to the lack of positive results in some TBI trials (Maas et al., 1999; Marmarou, 2001; 
Narayan et al., 2002). A study by Choi and colleagues (Choi et al., 2002) indicated that the effect of 
misclassification on GOS may not only decrease the desired power of a trial, but also the size of 
true benefit. Thus observer variation or outcome misclassification may obscure therapeutic effects 
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by introducing errors into the true study efficacy. We (Lu et al., 2008) recently reported that a 20% 
random misclassification on a dichotomous GOS outcome could reduce the treatment effect from 
the expected 10% to 6.8%, while maintaining the statistical power as a fixed factor. 
 The consistency and reliability of the outcome assessment could be influenced by many 
factors. Thus a collective effort by all possible means should be made to ensure the quality of the 
assessment. Here we introduce an alternate GOSE rating system as an aid in determining GOSE 
scores with the objective of reducing inter-rater variation in the primary outcome assessment in TBI 
trials. 
 The method used in this study is based on the concept that the GOSE is an extension of the 
GOS and as such, effort is focused on obtaining a reliable GOS score, and then limiting the 
questions asked in order to obtain a reliable GOSE score.  More importantly, the method requires 
the investigator to record pre- and post-injury narratives to establish firm baselines, and source 
documentation that provides quality assurance through central monitoring to determine a reliable 
outcome and reduce clerical errors. 
 
Materials and Methods 
Study participation centers and design 
Forty-five trauma centers in the United States were invited to participate in this study. These 
centers are members of the active American Brain Injury Consortium (ABIC) currently selected to 
participate in a Phase III TBI trial. The selection was based on the centers’ past experience in TBI 
trials, the existing data regarding the annual volume of TBI patient enrollments, and the level of 
correspondence with ABIC. The selected centers were randomly divided into three study groups of 
equal size as balanced by the center’s past experiences in TBI trials. These three groups were 
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assigned to use different methods to assess patient 6-month GOSE outcome as described in Figure 
1. 
 
Figure 1.Forty-five trauma centers were randomly divided into three study groups balanced by each 
center’s past experience in TBI trials. Group 1 used the alternative GOS/GOSE rating system 
coupled with central quality control, in which the raters were required to complete six sets of pre- 
and post-injury narratives according to six sample transcripts prior to outcome assessment. Group 2 
used the alternative system with no central quality control, in which the raters used six sets of pre-
specified narratives to rate the outcome. These narratives contained information, strictly transferred 
from the original interview transcripts by an expert, which allowed the validation of GOS/GOSE 
assessment without errors introduced by incorrect narratives. Group 3 used conventional structured 
interviews in which the raters were required to fill out the structured GOSE interview 
questionnaires based on the same six transcripts, and to provide an overall GOSE rating of the case 
(GOS, Glasgow Outcome Scale; GOSE, Extended Glasgow Outcome Scale; TBI, traumatic brain 
injury). 
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 Group 1 used the alternative GOS/GOSE rating system coupled with central quality control, 
in which the raters were required to complete six sets of pre- and post-injury narratives according to 
six sample transcripts prior to the outcome assessment. Group 2 used the alternative system with no 
central quality control, in which the raters used six sets of pre-specified narratives to rate the 
outcome. These narratives contained information, strictly transferred from the original interview 
transcripts by an expert, which allowed the validation of GOS/GOSE assessment without errors 
introduced by incorrect narratives. Group 3 used conventional structured interviews in which the 
raters were required to fill out the structured GOSE interview questionnaires based on the same six 
transcripts, and to provide an overall GOSE score for the case. For each study group, the raters were 
given brief written instructions as to how to use the alternative system or conventional method to 
complete the outcome assessment. No additional training was given to the investigators. For study 
Group 1, the raters were informed that a central reviewer would monitor the rating process. 
 The alternative method was a web-based GOSE rating system, which required recording the 
structured pre- and post-injury narratives initially to establish firm baselines and source 
documentation. Based on the narratives, the system first captured the score on the five-point GOS 
according to six structured yes/no questionnaires. After the GOS category was defined, the system 
presented the raters with the criteria (Table 1) for the upper or lower strata of a particular GOS 
category in order to arrive at the GOSE. As such, only the questions relevant to the patient’s GOS 
category were presented. For example, if the GOS was rated as moderate disability, the electronic 
system would route the rater to a screen where only questions regarding the upper and lower strata 
of moderate disability were presented. A set of the pre and post injury narratives and GOS and 
GOSE checklists is available as an online only supplement. 
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 Moreover, a quality control system was built into the rating process that provided quality 
assurance through the use of a central reviewer. For instance, after the raters in Group 1 completed 
the pre- and post-injury narratives for each patient case, using information from the sample 
transcripts, a central reviewer would check whether the transferred narratives reflected accurate and 
sufficient information for assessing the outcome, compared with the original transcripts. The focus 
of the central review was to determine if there was sufficient information in all categories of the 
GOS/GOSE to arrive at an accurate assessment. Feedback from the central reviewer allowed the 
raters to re-check the narrative information if it was incomplete, or to proceed to the next step. The 
same quality control was performed after the raters completed each assessment of the five-point 
GOS and the eight-point GOSE, according to the raters’ narratives. The investigators made the final 
decision based on the overall rating and the comments from the central review. Care was taken not 
to lead the investigators to a specific rating, but only to ensure that the information in the narrative 
was sufficient based on classic guidelines for GOS/GOSE assessment. In this way, the narratives 
served as a verifiable source document for the GOS and GOSE assessments. 
Study material and outcome 
Six transcripts of structured outcome interviews with patients with head injury or their 
relatives were used in order to assess the GOSE outcome. These transcripts contained real patient 
data originating from previous studies, and were also used in the dexanabinol study (Wilson et al., 
2007) to assess baseline agreement between raters. The cases selected were not intended to be 
specifically representative of ‘‘easy’’ or ‘‘difficult’’ cases, but they covered the range of GOSE 
outcomes, from lower severe disability to lower good recovery, as assigned by an expert according 
to the criteria for the GOSE categories. The transcripts were distributed electronically to the study 
participating centers in two formats. For study Groups 1 and 3, the centers received the original 
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interview transcripts; for Group 2, the centers received six sets of pre-specified pre- and post-injury 
narratives that were transferred from the transcripts as described previously. No additional 
information regarding the outcome and the severity of injury were provided for these cases. 
Statistical analysis 
We analyzed the quality and inter-rater variation in GOS/GOSE assessment by the 
alternative GOSE data collection system (Groups 1 and 2). The results for outcome assessment were 
then compared against the results obtained using the conventional structured GOSE interviews 
(Group 3). 
To identify whether central quality control played an important role in reducing inter-rater 
variation in the assessment of GOSE for the alternative method, we first applied the descriptive 
analyses and listed the discrepancies found in each step of the central quality check-ups for Group 
1, including the steps of transferring patient responses from the original transcripts to pre-injury and 
post-injury narratives, and the assessments of the five-point GOS and the eight-point GOSE. We 
then compared the agreement rate in outcome ratings between the expert and the raters among all 
study groups. Further, to examine whether the two-stage GOSE assessment (i.e., assessing the five-
point GOS first, then the eight-point GOSE) by the alternative system was more effective in 
reducing inter-rater variation, we compared the ratings for both five-point GOS and eight-point 
GOSE for all three groups through cross-tabulations. 
The inter-rater agreement was assessed using weighted kappa (κ) statistics (Cohen, 1968). 
The weighted κ was developed to give more emphasis to the degree of disagreement. The 
conventional ‘‘weight’’ used for assessing disagreement in ordered categorical data was a quadratic 
weight. In general, the strength of agreement could be described by κ statistics as poor (<0.2), fair 
(>2 to _0.4), moderate (>0.4 to _0.6), good (>0.6 to _0.8), and very good (>0.8 to _1; Landis and 
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Koch, 1977). The weighted κ and its 95% confidence interval (CI), as well as the raw agreement 
rate were reported. 
 
Results 
Characteristics of the study centers 
A total of 45 trauma centers were invited to participate and 32 centers volunteered to 
complete the study. The overall participation rate was 71%, and the participation rates for Groups 1, 
2, and 3 were 67%, 73%, and 73%, respectively. The characteristics of the study participating 
centers and the raters’ past experience in TBI trials and their current occupation status are described 
in Table 2. 
 
The alternative GOSE rating system: Observation from central review 
The analysis regarding the rule of central quality control for the alternative GOSE rating 
system was conducted for study Group 1. The raters completed three processes sequentially through 
the electronic rating system: pre/post narratives, GOS rating and GOSE rating. Ten raters each 
completed the three processes, including the transfer of information to the narratives, and rating of 
GOS followed by rating of GOSE for six cases. Out of 60 sample cases and 180 rating processes, 
the central reviewer identified 28 (28 out of 180) discrepancies, including 13 (13 out of 60) 
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discrepancies in the process of writing the post narratives, six (6 out of 60) in the five-point GOS 
assessment, and nine (9 out of 60) in the eight-point GOSE assessment. The investigators made the 
final decision on the overall rating, and the comments from central review resulted in rectifying 26 
of the 28 discrepancies. 
Major reasons for the discrepancies identified by the central reviewer for Group 1 are 
summarized in Table 3. Out of 13 discrepancies that occurred in the process of writing the post 
narratives, nine of those were because the raters did not respond to the specific questions that were 
required by the post narratives, while four cases were attributable to the raters’ misinterpretation of 
the original information from the transcripts. For the six and nine discrepancies that were identified 
for the GOS and GOSE ratings, respectively, almost all discrepancies occurred because of incorrect 
outcome ratings based on the narratives. Namely, the narratives were correct, but the outcome rating 
was not in agreement with the narratives. 
 
Observer variation in assessment of the eight-point GOSE 
The evaluation of consistency in eight-point GOSE assessment was conducted for all study 
groups as shown in Table 4a.  For study Group 1, which was assigned to use the alternative GOSE 
rating system, the overall agreement in GOSE  assessment between a central reviewer and the raters 
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was 97% (weighted κ=0.97; 95% CI 0.91, 1.00). This agreement rate was based on both 
investigators’ overall rating and the central reviewer’s comments. On two occasions the investigator 
disagreed with the comments from the central reviewer. 
 
Group 2 utilized the alternative rating system as well, but with no central quality control. 
The overall agreement rate in GOSE assessments between an expert and untrained raters was 76% 
(weighted κ=0.79; 95% CI 0.69, 0.89). In general, the raters did well in assessing the categories of 
lower and upper severe disabilities, for which the agreement rate between the central reviewer and 
raters reached 92% and 100%, respectively.  However, the raters seemed to have more problems 
when assessing the sample cases of moderate disability and good recovery. The agreement rates in 
assessing the lower moderate GOSE equaled 45%, upper moderate GOSE 82%, and lower good 
GOSE 55%. 
For the six lower moderate disability cases that an expert and the raters disagreed upon, five 
were due to the judgment of the patient’s current occupational status and/or the degree of the social 
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and leisure activities resumed. In four disputed upper moderate disability cases, three were related 
to the inquiry as to whether the patients’ current ability to drive or use public transportation was due 
to head injury or for some other reason. Finally, for five lower good recovery cases, four were not 
agreed upon as to whether the patient was able to return to their prior injury social and leisure 
activities by at least 50%. 
Compared with the groups using the alternative rating system, the overall agreement 
between an expert and raters in Group 3 was lower. The overall agreement for Group 3 only 
reached 63% (weighted κ=0.70; 95% CI 0.60, 0.81). The agreement rates between an expert and the 
raters in assessing the categories were as follows: lower and upper severe disabilities (55% and 
82%), lower and upper moderate disabilities (55% and 60%), and lower good recovery (64%).  
Moreover, the observed assessment disparity among the outcome categories was wider, especially 
in the assessment of moderate disabilities. 
For the severe disability cases, except for one case of misunderstanding, six mistakes were 
due to algorithm issues. For the moderate disability categories, the majority of errors were in the 
area of social and leisure activities and/or current occupational status, for which the raters were 
required to exercise their own judgment in assessing if the social and leisure activities were more or 
less than 50%. Finally, the errors in rating the good recovery category were also seen mostly in the 
area of social and leisure activities. 
Observer variation in assessment of the five-point GOS 
The observer variation in the assessment of the five-point GOS is summarized in Table 4b. 
The performance on the five-point GOS rating scale was generally better among all study groups 
compared to the eight-point GOSE assessment. For Groups 1 and 2, that used the alternative 
approach to rate the outcome, the overall agreement between an expert and the raters were 97% 
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(weighted κ=0.95; 95% CI 0.89, 1.00), and 83% (weighted κ=0.81; 95% CI 0.69, 0.92), 
respectively. For Group 3, that used the conventional method, the overall agreement reached 83% 
(weighted κ=0.76; 95% CI 0.63, 0.89). 
 
In accordance with the assessment of the eight-point GOSE, the raters did well on rating 
severe disability. The agreement rate between an expert and the raters for Groups 1 and 2 reached 
100% and 100%, respectively, and the rate for Group 3 was 91%. However, the raters were less in 
agreement with the expert in the assessment of better GOS outcome categories. For Groups 1, 2, 
and 3, the agreement rates were 97%, 85%, and 76%, in the assessment of moderate disabilities, and 
90%, 64%, and 82% in the assessment of good recovery, respectively. 
 
Discussion 
In this study, we used an alternative GOSE rating system to aid the assignment of outcome 
scores with the objective of reducing the inter-rater variation in the primary outcome assessment in 
TBI trials. The proposed system is an extension of the existing ABIC five-point GOS checklist, 
which was developed for the purpose of reducing inter-rater variation in GOS assessment in TBI 
trials (Wilson et al., 1998). The GOS checklist has been shown to decrease inter-observer variability 
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in a pilot trial (Marmarou, 2001), and was used in two TBI clinical trials (Marmarou et al., 1999, 
2005). The current system adds additional criteria, while maintaining the five-point GOS rating 
criteria, to assess the use of the eight-point GOSE system, as directed by the guidelines (Wilson et 
al., 1998). In addition, the alternative system takes advantage of electronic data capture to (1) 
integrate a quality-control system into the rating process, which provides improved quality 
assurance through use of a central reviewer, (2) utilize an algorithm to arrive at the GOS score, and 
(3) to only present the questions separating the upper and lower categories of a specific GOS rating 
to arrive at the GOSE score. 
The results of this study indicate that inter-rater variations in the outcome assessment can be 
reduced through the improved outcome data collection system. For study Group 1, which utilized 
the complete alternative system in which a central quality-control system was built into the rating 
process, the overall agreement rate between an expert and the raters in the  assessment of the five-
point GOS (weighted κ=0.95; 95% CI 0.89, 1.00), and the eight-point GOSE (weighted κ=0.97; 
95% CI   0.91, 1.00), reached 97%. These results are superior to those of previous studies (Brooks 
et al., 1986; Maas et al., 1983; Marmarou, 2001; Wilson et al., 1998, 2007), as shown in Table 5. 
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Furthermore, the use of the alternative system alone (Group 2), without central monitoring, 
also demonstrated strength in lessening the variation in the eight-point GOSE assessment among 
untrained raters, especially in the assessment of lower and upper severe disability categories (Table 
4a). The overall agreement, weighted κ, and CI [GOS 83%, 0.81, and (0.69, 0.92),   GOSE 76%, 
0.79, and (0.69, 0.89)] in the outcome assessment were better than the results reported earlier, and 
consistent with more recent results (Marmarou, 2001; Wilson et al., 1998, 2007). The results from 
Group 3, that used the conventional structured interviews, are in close agreement with the baseline 
variability found in the dexanabinol trial. (Wilson et al., 2007). 
Moreover, this study provided valuable insights into (1) potential causes of inter-rater 
variations during the outcome assessment process, and (2) the impact of an improved outcome 
rating system on constraining such variations in the course of assessment. The proposed system may 
help reduce the variation in the assessment of the eight-point GOSE through the following 
approaches. 
Pre-injury narratives 
The first step in this alterative system was to collect a pre-injury narrative within 2 weeks 
post-injury. This helped in determining the true impact of head injury on an individual’s daily 
functioning, by taking into consideration the pre-injury status for each of the areas included in the 
GOS and GOSE assessment scales. Given the performance of Group 1 raters, the description and 
format of the pre-injury narrative appeared to be sufficient to serve as an important baseline 
reference. In comparison with sample cases, no disagreement with the narratives was shown 
between the central reviewer and raters. Thus it appears that these narratives in the module are user-
friendly and self-exploratory for future use in TBI trials. 
Three- and six-month post-injury narratives 
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Since this alternative system requires an investigator responsible for the outcome assessment 
to collect the data for the 3- and 6-month post-injury narratives after documenting patient function 
as described above for the pre-injury narratives, this indicates that each patient serves as their own 
control. As such, a reduction in GOS score will more clearly reflect the result of the patient’s head 
injury. These narratives provide not only the necessary information for the outcome rating, but also 
critical source documentation for the purpose of quality control. 
In this study, we found that most raters were able to properly record the post-injury 
information according to the descriptions of the post-injury narratives. Out of 13 post-injury 
narratives that the central reviewer had to query, nine cases were due to the raters’ failure to 
respond to the questions required, and four were caused by the raters’ misinterpretation of sample 
cases. At least two main reasons may explain these errors. For instance, the raters’ prior knowledge 
and experience in utilizing a rating instrument may be an important factor. In the absence of 
knowledge of the basic concepts and understanding of the outcome and rating process, a rater does 
not possess the information necessary to assess the outcome, even when the information is 
available, as suggested by the results of several previous studies. In this regard, Clifton and 
colleagues (2001) demonstrated that higher-enrollment centers were superior in data completion, 
outcome assessment, and overall patient management, compared to lower-enrollment centers. 
Wilson and associates (2007) also showed that the central review identified a relatively large 
number of discrepancies (29–37%) during the early stages of a trial, but the number declined as the 
trial progressed, which coincided with more extensive investigator training and feedback from the 
central review. 
Moreover, a loosely-structured question format leads to an open-ended answer and 
flexibility for the raters to provide their answers. As such, using a mixture of open-ended and pre-
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categorized answers would be expected to improve data collection. For example, loosely-structured 
more open-ended answers allows raters to better document an individual’s post-injury condition, 
while the fixed pre-categorized answers facilitates a standardized outcome rating among the patient 
population. This   may be particularly meaningful with regard to the key concepts that differentiate 
the GOS and GOSE categories, as shown in Table 1. 
 It should be pointed out that in this study, the raters were able to obtain feedback from a 
central reviewer and had the opportunity to correct an error in narrative writing before the rating 
process. Thus, we recommend (1) acquiring the necessary 
knowledge about the outcome and its assessment instrument prior to a trial, (2) practicing on sample 
cases before the actual assessment is carried out, (3) collecting complete information in accordance 
with the requirements outlined in the narratives, and (4) checking the consistency of their own 
narratives. 
A two-stage GOS and GOSE rating system 
The alternative GOSE rating system requires the investigators to rate the less complicated 
five-point GOS first, followed by rating the eight-point GOSE category, by subdividing the selected 
GOS category into a ‘‘lower’’ or ‘‘upper’’ category. The rating on the five-point GOS is based on a 
checklist that contains the same category and layout of the source documentation (i.e., the pre- and 
post-injury narratives). But the eight-point GOSE rating is based on a compilation sheet in which 
the information is extracted from the pre-categorized answers of the post-injury narrative sheet. 
Thus, this system provides a two-stage rating process, thereby minimizing potential observer 
variations across the five-point GOS outcome categories, and simplifies the assessment of the eight-
point GOSE. 
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To date, this system has been used to collect 6-month GOSE data for an observational study, 
including both U.S and European centers. In this validation study, we found that a two-stage 
outcome rating system was, in general, an improvement over the conventional approach in the 
eight-point GOSE assessment. The improvement was particularly noticeable in the assessment of 
severe disability. For instance, of 22 lower and upper severe disability sample cases, the expert had 
only one disagreement with the ratings obtained from Group 2, in which the two-stage system was 
used, whereas the expert had seven disagreements (7/22) from Group 3, in which the conventional 
method was applied. It seems that the more reliable rating outcome for Group 2 was directly related 
to the use of the two-stage system, which simplified the rating process and automated the rating 
algorithms. This is especially evident in light of the fact that neither group received feedback from 
the central quality control, and both used the same sample cases. 
Study limitations 
Although studies of inter-rater variations using central reviews or ratings from sample cases 
can reveal inconsistencies in outcome assessment, they are unlikely to capture every potential type 
of variation. In practice, the outcome assessment may be more complex, and the results may be 
further influenced by how the questions are asked and responses are solicited. Thus, the inter-
observer agreements obtained in this study, based on sample transcripts, cannot be directly 
extrapolated to the clinical situation when assessing actual patients. Also, the results of this study 
were obtained from a relatively small group of investigators. Further study with larger groups of 
investigators in actual interview situations are needed to further confirm the results of this study. 
Moreover, the method of using case histories does not allow further information to be gathered over 
what has already been collected in the sample cases. 
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Nevertheless, since the sample cases used in this study were originally obtained through the 
structured interviews, and used in a large Phase III head injury trial GOSE inter-observer variation 
study (Wilson et al., 2007), it was reasonable to believe that the information obtained from these 
cases included sufficient information to assess patient outcome. Therefore, we believe that these 
sample cases are useful to validate whether (1) the criteria described in the narratives provide 
sufficient information for outcome assessment, and (2) the alternative GOSE rating system itself is 
better at reducing variations in GOSE assessment than conventional structured interviews. 
 
Conclusion 
The results of this study indicate that the alternative method for GOSE assessment has 
several advantages over current techniques. First, a narrative provides source documentation about 
the pre-injury status, and the status at 3 and 6 months post-injury, thus allowing for a more thorough 
central review. Second, a GOS-structured checklist provides an easy and practical method for GOS 
assessment. Third, an electronic system that directs the investigator to focus on an upper or lower 
classification of the GOSE criteria provides an easy and practical method for GOSE assessment. 
Taken together these elements, coupled with the central review, allow a more reliable GOSE rating 
system, thus reducing inter-rater variation and misclassification. The results of this study emphasize 
the importance of combining all efforts to reduce outcome misclassification, including the use of a 
reliable outcome rating system, collection of sufficient standardized information, proper rater 
training, and central quality control. 
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